{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:25:27Z","timestamp":1794857127205,"version":"4.9.1"},"reference-count":88,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Primary aldosteronism (PA) is now recognized as the most prevalent form of secondary hypertension globally, contributing significantly to cardiovascular morbidity and mortality. This umbrella review aims to systematically compare cardiovascular outcomes and all-cause mortality in PA patients undergoing adrenalectomy versus mineralocorticoid receptor antagonist (MRA) treatment, aiming to inform optimal management strategies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>Following PRISMA guidelines (Supplemental Digital Content 1, http:\/\/links.lww.com\/JS9\/D386) (Supplemental Digital Content 2, http:\/\/links.lww.com\/JS9\/D387), a comprehensive search strategy was employed across multiple databases. Meta-analyses focusing on cardiovascular outcomes or all-cause mortality, comparing adrenalectomy and MRAs treatment in PA patients, were included. Studies were independently screened and assessed for quality using AMSTAR 2 (Supplemental Digital Content 3, http:\/\/links.lww.com\/JS9\/D388) and GRADE checklists.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of eight studies met the inclusion criteria. Adrenalectomy showed potential benefits over MRAs in reducing the risk of arrhythmias (OR=2.17; 95% CI: 1.25\u20133.76) and major adverse cardiovascular events (OR=1.81; 95% CI: 1.33\u20132.46). Patients treated with MRAs exhibited a higher risk of cardiovascular events (OR=1.23; 95% CI: 1.05\u20131.44), hypertension (OR=3.22; 95% CI: 1.15\u20138.97), and all-cause mortality (OR=3.03; 95% CI: 1.36\u20136.70) compared to adrenalectomy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Adrenalectomy appears to offer favorable outcomes compared to MRAs treatment in PA patients, particularly in reducing the risk of major adverse cardiovascular events and all-cause mortality. These findings suggest the importance of considering surgical intervention as a primary treatment modality for PA.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000002048","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T09:49:29Z","timestamp":1725875369000},"page":"7367-7380","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: an umbrella review"],"prefix":"10.1097","volume":"110","author":[{"given":"Sandeep S.","family":"Nayak","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Hospital Medicine, Yale New Haven Health, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Amini-Salehi","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farahnaz","family":"Joukar","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pubali","family":"Biswas","sequence":"additional","affiliation":[{"name":"Vydehi Institute of Medical Sciences and Research Centre, Whitefield, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nobakht","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Letafatkar","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Medicine, Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Porteghali","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Guilan University of Medical Sciences, Rasht, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfan","family":"Mohammadi-Vajari","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz","family":"Mansour-ghanaei","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Javid","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Mirdamadi","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniyal","family":"Ameen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hospital Medicine, Yale New Haven Health, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrang","family":"Motamed","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Guilan University of Medical Sciences, Rasht, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-4908","authenticated-orcid":false,"given":"Soheil","family":"Hassanipour","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Hossein","family":"Keivanlou","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences"},{"name":"Student Research Committee, School of Medicine, Guilan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11]]},"reference":[{"key":"R1-20250824","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ajh\/hpac079","article-title":"Primary aldosteronism: state-of-the-art review","volume":"35","author":"Vaidya","year":"2022","journal-title":"Am J Hypertens"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-44-1-1","article-title":"Primary aldosteronism, a new clinical entity","volume":"44","author":"Conn","year":"1956","journal-title":"Ann Intern Med"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary aldosteronism: practical approach to diagnosis and management","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","article-title":"Secondary arterial hypertension: when, who, and how to screen?","volume":"35","author":"Rimoldi","year":"2014","journal-title":"Eur Heart J"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"927669","DOI":"10.3389\/fendo.2022.927669","article-title":"Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome","volume":"13","author":"Santana","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tem.2005.02.010","article-title":"Aldosterone as a cardiovascular risk factor","volume":"16","author":"Rossi","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/HJH.0000000000002250","article-title":"Atrial fibrillation as presenting sign of primary aldosteronism: results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study","volume":"38","author":"Seccia","year":"2020","journal-title":"J Hypertens"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/HYPERTENSIONAHA.123.21895","article-title":"Mortality in patients with primary aldosteronism: a Swedish nationwide study","volume":"80","author":"Gkaniatsa","year":"2023","journal-title":"Hypertension"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"E900","DOI":"10.1210\/jc.2014-4167","article-title":"Primary aldosteronism and ARMC5 variants","volume":"100","author":"Zilbermint","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijcard.2012.10.046","article-title":"Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations","volume":"168","author":"Finegold","year":"2013","journal-title":"Int J Cardiol"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1055\/s-0043-122602","article-title":"Subtyping of patients with primary aldosteronism: an update","volume":"49","author":"Lenders","year":"2017","journal-title":"Horm Metab Res"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jamcollsurg.2010.05.006","article-title":"Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease","volume":"211","author":"Mathur","year":"2010","journal-title":"J Am Coll Surg"},{"key":"R18-20250824","first-page":"1066","article-title":"Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism1","volume":"86","author":"Magill","year":"2001","journal-title":"J Clin Endocrinol Metabol"},{"key":"R19-20250824","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Matthew","year":"2021","journal-title":"BMJ"},{"key":"R20-20250824","first-page":"j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Beverley","year":"2017","journal-title":"BMJ"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"646933","DOI":"10.3389\/fendo.2021.646933","article-title":"New-onset atrial fibrillation in patients with primary aldosteronism receiving different treatment strategies: systematic review and pooled analysis of three studies","volume":"12","author":"Tsai","year":"2021","journal-title":"Front Endocrinol"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41440-019-0244-4","article-title":"Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism","volume":"42","author":"Satoh","year":"2019","journal-title":"Hypertens Res"},{"key":"R24-20250824","doi-asserted-by":"crossref","first-page":"e1280","DOI":"10.1210\/clinem\/dgad654","article-title":"Time to benefit of surgery vs. targeted medical therapy for patients with primary aldosteronism: a meta-analysis","volume":"109","author":"Samnani","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-20250824","first-page":"300","article-title":"Stroke risks in primary aldosteronism with different treatments: a systematic review and meta-analysis","volume":"9","author":"Qian","year":"2022","journal-title":"J Cardiovasc Developm Dis"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ajh\/hpu154","article-title":"Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies","volume":"28","author":"Marzano","year":"2015","journal-title":"Am J Hypertens"},{"key":"R27-20250824","doi-asserted-by":"crossref","first-page":"147032032110037","DOI":"10.1177\/14703203211003781","article-title":"Cardiovascular events and all-cause mortality in surgically or medically treated primary aldosteronism: a meta-analysis","volume":"22","author":"Jing","year":"2021","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"644260","DOI":"10.3389\/fendo.2021.644260","article-title":"Composite cardiovascular outcomes in patients with primary aldosteronism undergoing medical versus surgical treatment: a meta-analysis","volume":"12","author":"Huang","year":"2021","journal-title":"Front Endocrinol"},{"key":"R29-20250824","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1530\/EJE-22-0375","article-title":"Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis","volume":"187","author":"Chen","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"7417242","DOI":"10.1155\/2020\/7417242","article-title":"Association of Race and Major Adverse Cardiac Events (MACE): the Atherosclerosis Risk in Communities (ARIC) Cohort","volume":"2020","author":"Franey","year":"2020","journal-title":"J Aging Res"},{"key":"R31-20250824","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","article-title":"Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review","volume":"21","author":"Bosco","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"R32-20250824","doi-asserted-by":"crossref","first-page":"E773","DOI":"10.1503\/cmaj.161486","article-title":"Primary aldosteronism: a common cause of resistant hypertension","volume":"189","author":"Kline","year":"2017","journal-title":"CMAJ"},{"key":"R33-20250824","doi-asserted-by":"crossref","first-page":"14","DOI":"10.21037\/gs.2019.10.23","article-title":"Primary aldosteronism","volume":"9","author":"Wrenn","year":"2020","journal-title":"Gland Surg"},{"key":"R34-20250824","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fendo.2020.00121","article-title":"Long-term mortality for patients of primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"11","author":"Meng","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R35-20250824","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/jc.2008-2116","article-title":"Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn\u2019s Registry","volume":"94","author":"Born-Frontsberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-20250824","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"R37-20250824","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/HJH.0000000000002070","article-title":"Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism","volume":"37","author":"Katabami","year":"2019","journal-title":"J Hypertens"},{"key":"R38-20250824","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"R39-20250824","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"R40-20250824","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ajh.2010.169","article-title":"Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment","volume":"23","author":"Sechi","year":"2010","journal-title":"Am J Hypertens"},{"key":"R41-20250824","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/HJH.0000000000000464","article-title":"Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness","volume":"33","author":"Holaj","year":"2015","journal-title":"J Hypertens"},{"key":"R42-20250824","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/HJH.0000000000002679","article-title":"Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: A meta-analysis of echocardiographic studies","volume":"39","author":"Cuspidi","year":"2021","journal-title":"J Hypertens"},{"key":"R43-20250824","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cen.14351","article-title":"Outcomes in unilateral primary aldosteronism after surgical or medical therapy","volume":"94","author":"Puar","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R44-20250824","doi-asserted-by":"crossref","first-page":"32103","DOI":"10.1038\/srep32103","article-title":"Long term outcome of aldosteronism after target treatments","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"R45-20250824","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"R46-20250824","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"R47-20250824","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R48-20250824","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R49-20250824","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R50-20250824","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R51-20250824","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"R52-20250824","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0895-7061(02)03021-2","article-title":"Left ventricular changes in primary aldosteronism","volume":"16","author":"Rossi","year":"2003","journal-title":"Am J Hypertens"},{"key":"R53-20250824","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1210\/jc.2011-0354","article-title":"Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study","volume":"96","author":"Pimenta","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-20250824","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/HYPERTENSIONAHA.108.114140","article-title":"Inappropriate left ventricular mass in patients with primary aldosteronism","volume":"52","author":"Muiesan","year":"2008","journal-title":"Hypertension"},{"key":"R55-20250824","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"J Hypertens"},{"key":"R56-20250824","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","article-title":"Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension","volume":"25","author":"Holaj","year":"2007","journal-title":"J Hypertens"},{"key":"R57-20250824","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1507\/endocrj.K09E-014","article-title":"Endothelial dysfunction is related to aldosterone excess and raised blood pressure","volume":"56","author":"Tsuchiya","year":"2009","journal-title":"Endocr J"},{"key":"R58-20250824","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jc.2012-3934","article-title":"Aldosterone excess impairs first phase insulin secretion in primary aldosteronism","volume":"98","author":"Fischer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R59-20250824","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/ATVBAHA.111.240697","article-title":"Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor","volume":"32","author":"Sherajee","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R60-20250824","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"R61-20250824","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10557-018-6783-0","article-title":"Association of abnormal serum potassium levels with arrhythmias and cardiovascular mortality: a systematic review and meta-analysis of observational studies","volume":"32","author":"Hoppe","year":"2018","journal-title":"Cardiovasc Drugs Ther"},{"key":"R62-20250824","doi-asserted-by":"crossref","first-page":"e93136","DOI":"10.1172\/jci.insight.93136","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt","year":"2017","journal-title":"JCI Insight"},{"key":"R63-20250824","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"key":"R64-20250824","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"R65-20250824","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/HJH.0b013e3283550f93","article-title":"Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism","volume":"30","author":"Lin","year":"2012","journal-title":"J Hypertens"},{"key":"R66-20250824","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/HYPERTENSIONAHA.116.08956","article-title":"Arterial hypertension, atrial fibrillation, and hyperaldosteronism: the triple trouble","volume":"69","author":"Seccia","year":"2017","journal-title":"Hypertension"},{"key":"R67-20250824","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1074\/jbc.M113.519256","article-title":"The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation","volume":"289","author":"Lavall","year":"2014","journal-title":"J Biol Chem"},{"key":"R68-20250824","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijcard.2013.06.046","article-title":"Cross-talk between mineralocorticoid receptor\/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes","volume":"169","author":"Tsai","year":"2013","journal-title":"Int J Cardiol"},{"key":"R69-20250824","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/eurheartj\/ehr266","article-title":"Aldosterone promotes atrial fibrillation","volume":"33","author":"Reil","year":"2012","journal-title":"Eur Heart J"},{"key":"R70-20250824","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","article-title":"Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications","volume":"66","author":"Dzeshka","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R71-20250824","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/a-1141-5989","article-title":"Atrial fibrillation in primary aldosteronism","volume":"52","author":"Pan","year":"2020","journal-title":"Horm Metab Res"},{"issue":"S1","key":"R72-20250824","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2105\/AJPH.2017.303780","article-title":"The dental professional","volume":"107","author":"Batliner","year":"2017","journal-title":"Am J Public Health"},{"key":"R73-20250824","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment","volume":"103","author":"Velema","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R74-20250824","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jbmr.3033","article-title":"Risk of fracture in primary aldosteronism: a population-based cohort study","volume":"32","author":"Wu","year":"2017","journal-title":"J Bone Miner Res"},{"key":"R75-20250824","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R76-20250824","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J Hypertens"},{"key":"R77-20250824","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2017.03.011","article-title":"True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: a meta-analysis","volume":"188","author":"Vukadinovic","year":"2017","journal-title":"Am Heart J"},{"key":"R78-20250824","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"N Engl J Med"},{"key":"R79-20250824","first-page":"7","article-title":"Evaluation and management of the incidental adrenal mass","volume":"16","author":"Arnold","year":"2003","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"R80-20250824","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1530\/EJE-21-0650","article-title":"Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses","volume":"186","author":"Schloetelburg","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"R81-20250824","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/107327480200900407","article-title":"Evaluation and management of adrenal masses","volume":"9","author":"Moreira","year":"2002","journal-title":"Cancer Control"},{"key":"R82-20250824","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1007\/s00261-015-0521-x","article-title":"CT sensitivity for adrenal adenoma according to lesion size","volume":"40","author":"Park","year":"2015","journal-title":"Abdom Imaging"},{"key":"R83-20250824","doi-asserted-by":"crossref","first-page":"5563881","DOI":"10.1155\/2023\/5563881","article-title":"Adrenal vein sampling in the management of primary aldosteronism: the added value of intraprocedural cortisol assessment","volume":"2023","author":"Manique","year":"2023","journal-title":"Int J Endocrinol"},{"key":"R84-20250824","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/ajh.2011.148","article-title":"Intraprocedural cortisol measurement increases adrenal vein sampling success rate in primary aldosteronism","volume":"24","author":"Rossi","year":"2011","journal-title":"Am J Hypertens"},{"key":"R85-20250824","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/ijem.ijem_177_22","article-title":"Adrenal venous sampling in primary aldosteronism: single-centre experience from Western India","volume":"27","author":"Rathod","year":"2023","journal-title":"Indian J Endocrinol Metab"},{"key":"R86-20250824","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1097\/HJH.0b013e32834666af","article-title":"Adrenal venous sampling is crucial before an adrenalectomy whatever the adrenal-nodule size on computed tomography","volume":"29","author":"Sarlon-Bartoli","year":"2011","journal-title":"J Hypertens"},{"key":"R87-20250824","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","article-title":"[11C] metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial","volume":"29","author":"Wu","year":"2023","journal-title":"Nat Med"},{"key":"R88-20250824","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1210\/clinem\/dgaa952","article-title":"Approach to the patient with primary aldosteronism: utility and limitations of adrenal vein sampling","volume":"106","author":"Turcu","year":"2021","journal-title":"J Clin Endocrinol Metabol"},{"key":"R89-20250824","doi-asserted-by":"crossref","first-page":"e038489","DOI":"10.1136\/bmjopen-2020-038489","article-title":"Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis","volume":"10","author":"Zhou","year":"2020","journal-title":"BMJ Open"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:01:42Z","timestamp":1756062102000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":88,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002048","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"2024-03-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}